Emerging Infections Programs

Objective

The purpose of the Emerging Infections Programs (EIP) is to assist in local, state, and national efforts to prevent, control, and monitor the public health impact of infectious diseases. The EIP cooperative agreement was formed in 1995 as a key component of CDC’s national strategy to address and reduce emerging infectious disease (EID) threats. The EIP is a population-based network of state health agencies and their collaborators, including (but not limited to) academic institutions, local health departments, public health and clinical laboratories, infection control professionals, and healthcare providers. The unique strength of the EIP lies in the network’s ability to quickly translate surveillance and research activities into informed policy and public health practice.

Who Can Apply

• U.S. State Government (including the District of Columbia)
• Department or Agency of a U.S. State Government
• Department or Agency of a U.S. Territorial Government
• U.S. Territory (or Possession) Government (including freely-associated states)
• County Government (inclusive of boroughs in Alaska, parishes and other governmental entities with geographic regional control and authority)
• Municipality or Township government (inclusive of cities, towns, boroughs (except in Alaska), and villages)
• Other Local Government Consortium, Regional Organization (Intrastate), or Other Local Government Combination
• Local
• State
• Territorial

Who Benefits

Beneficiaries of this program include State and local health departments, the District of Columbia, U.S. Territories, and the general public.

Assistance Types

• Cooperative Agreement

Program Contact

roa3@cdc.gov
404-639-6146